Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/TAKEDA-PHARMACEUTICAL-COM-6491073/nieuws/Takeda-koopt-rechten-op-behandeling-van-epilepsie-van-Ovid-voor-maximaal-856-miljoen-dollar-32591943/?utm_source=whatsapp&utm_medium=social&utm_campaign=share